Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817

1. Paz-Ares, L.G.
2. Ciuleanu, T.-E.
3. Pluzanski, A.
4. Lee, J.-S.
5. Gainor, J.F.
6. Otterson, G.A.
7. Audigier-Valette, C.
8. Ready, N.
9. Schenker, M.
10. Linardou, H.
11. Caro, R.B.
12. Provencio, M.
13. Zurawski, B.
14. Lee, K.H.
15. Kim, S.-W.
16. Caserta, C.
17. Ramalingam, S.S.
18. Spigel, D.R.
19. Brahmer, J.R.
20. Reck, M.
21. O'Byrne, K.J.
22. Girard, N.
23. Popat, S.
24. Peters, S.
25. Memaj, A.
26. Nathan, F.
27. Aanur, N.
28. Borghaei, H.
29. Mostrar todos los/as autores/as +